• Schouw & Co. targets average annual organic revenue growth of 5-7%, EBITDA of DKK 4.5 billion and 15% ROIC by 2030.
• GPV aims for revenue around DKK 15 million, including acquisitions, with an EBITDA margin around 10%.
• HydraSpecma targets revenue above DKK 5 billion, following annual revenue growth around 10% since 2020.
• Spectre targets revenue of DKK 1.7-2 billion while maintaining EBITDA margins of 15-17%; production capacity is already in place.
• BioMar’s 2026 IPO generated approximately DKK 2.6 billion in net proceeds, increasing financial flexibility; the retained ownership stake is 74%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schouw & Co. A/S published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.